Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
Epidermal growth factor receptor (EGFR) activation has been shown to play a critical role in tumor angiogenesis. In this study, we investigate the correlation between EGFR mutations and cadherin-5 (CDH5), which is an angiogenic factor, in lung cancer cells. Increased expression CDH5 is observed in l...
Main Authors: | Ming-Szu Hung, I-Chuan Chen, Jr-Hau Lung, Paul-Yann Lin, Ya-Chin Li, Ying-Huang Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4928829?pdf=render |
Similar Items
-
Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
by: Gina Amanda, et al.
Published: (2017-01-01) -
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01) -
Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
by: Carlos E. Bacchi, et al.
Published: (2012-01-01) -
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
by: S.E.D.C. Jorge, et al.
Published: (2014-11-01) -
Epidermal Growth Factor Receptor Mutations and Radiotherapy
in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)